Lurbinectedin

CHEBI:CHEBI_749332

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2374738
generic_name
LURBINECTEDIN
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
listing_expiration_date
20251231
marketing_start_date
20200615
route
INTRAVENOUS
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
active_ingredient_strength
4 mg/8mL
pharm_class_moa
Alkylating Activity [MoA]
pharm_class
Alkylating Drug [EPC]
pharm_class_epc
Alkylating Drug [EPC]
package_marketing_start_date
30-MAY-23
nui
N0000175558
labeler_name
GP PHARM SA
brand_name
ZEPZELCA
brand_name_base
ZEPZELCA
product_ndc
69112-102
application_number
NDA213702
manufacturer_name
Jazz Pharmaceuticals, Inc.
spl_id
0bac816d-1a62-da3f-e063-6394a90af6c3
active_ingredient_name
LURBINECTEDIN
package_ndc
69112-102-01
package_description
8 mL in 1 VIAL, SINGLE-DOSE (69112-102-01)
unii
2CN60TN6ZS
spl_set_id
632bb50c-3bcb-4c85-9056-fc33410550ae
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class